Overcoming Inefficiencies in Clinical Trial Patient Matching
Matching patients to the correct clinical trials has traditionally been inefficient and error-prone, often relying on manual processes and incomplete data. These challenges resulted in missed opportunities, slowing down the trial enrollment process and affecting treatment timelines.The client faced significant challenges in accurately matching patients with suitable clinical trials. Traditional methods could not process large, complex datasets, leading to delays in finding appropriate trials, missed enrollment opportunities, and suboptimal trial recruitment.
AI-Powered Solution for Enhanced Trial Matching Accuracy
The Clinical Trial Match solution was designed by Ideas2it leveraging MolecularMatch, a leader in clinical informatics company with expertise in precision oncology, immunotherapy, and bioinformatics, combined with clinical insights empowering solution. The solution involved the integration of various advanced technologies to provide a seamless, scalable platform for clinical trial matching.
Key technical components included:
AI Models for Data Inconsistency Detection: The AI models were trained to identify discrepancies across multiple data sources. By cross-referencing trial data against pre-established patterns, historical data, and clinical benchmarks, the system could pinpoint inconsistencies that might have otherwise gone unnoticed. Once identified, the system flagged these inconsistencies for immediate review and resolution.
Missing Data Identification and Rectification: Missing data is one of the most significant issues in clinical trials, often resulting from incomplete forms, errors in data entry, or patients dropping out. The AI models were designed to not only identify missing data points but also suggest possible values based on statistical patterns, predictive models, and available contextual information. This helped fill gaps in a way that maintained the integrity of the data, ensuring completeness for analysis.
Anomaly Detection: The AI system employed advanced machine learning algorithms to detect outliers or anomalies in trial data, such as unexpected spikes in measurements or unusual patient outcomes. By analyzing trends over time and comparing them to historical patterns, the system could quickly identify anomalies that might indicate issues like data entry errors or experimental biases.
Standardization to Regulatory Standards: After detecting and correcting errors, the data was standardized to the CDISC SDTM (Study Data Tabulation Model) standards, which are recognized by regulatory authorities like the FDA and EMA.
Technologies Used
MolecularMatch Algorithm: A proprietary algorithm that drives precise clinical trial matching by considering genomic and clinical factors.
AWS SageMaker: Used for model training, data processing, and real-time predictions, enabling the deployment of scalable machine learning models.
Docker: Containerization of models to ensure scalable and efficient deployment.
RESTful APIs: For real-time integration with external systems, providing seamless access to trial recommendations.
Cloud Infrastructure: Powered by AWS, ensuring scalability and real-time data processing capabilities.
Driving Precision, Speed, and Enrollment Efficiency in Clinical Trials
The Clinical Trial Match solution brought about substantial improvements in trial matching accuracy, speed, and patient access:
The predictive algorithm enhanced the accuracy of matching patients to relevant clinical trials. By processing detailed genomic, clinical, and demographic data, the platform generated more precise trial recommendations, leading to better treatment outcomes for patients.
The use of real-time machine learning models significantly reduced the time it took to match patients with clinical trials. What previously took 2-4 weeks was now completed in 4 to 8 hours, providing faster, actionable insights to facilitate trial enrollment.
The integration of genomic and clinical data ensured that patients had access to a broader range of clinical trials, including rare and specialized studies that were previously hard to identify. This expanded access allowed for bettertreatment options and a higher likelihood of success.
The solution led to a higher rate of patient enrollment in clinical trials. By streamlining the matching process, more patients were quickly identified for suitable trials, which accelerated research timelines and improved treatment options for patients
The Clinical Trial Match solution successfully transformed the process of matching patients to clinical trials by leveraging predictive analytics, machine learning, and scalable cloud infrastructure. This solution provides better access to life-saving clinical trials.
This is some text inside of a div block.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
How Ideas2IT Built an AI-Powered Clinical Trial Match Platform for a Leading Pharmaceutical Company
How Ideas2IT Built an AI-Powered Clinical Trial Match Platform for a Leading Pharmaceutical Company
Solutions Deployed:
MolecularMatch Search Engine
Real-Time Predictions
Cloud-Based Infrastructure for Scalability
Vertical:
Pharma & Life Sciences
Overcoming Inefficiencies in Clinical Trial Patient Matching
Matching patients to the correct clinical trials has traditionally been inefficient and error-prone, often relying on manual processes and incomplete data. These challenges resulted in missed opportunities, slowing down the trial enrollment process and affecting treatment timelines.The client faced significant challenges in accurately matching patients with suitable clinical trials. Traditional methods could not process large, complex datasets, leading to delays in finding appropriate trials, missed enrollment opportunities, and suboptimal trial recruitment.
AI-Powered Solution for Enhanced Trial Matching Accuracy
The Clinical Trial Match solution was designed by Ideas2it leveraging MolecularMatch, a leader in clinical informatics company with expertise in precision oncology, immunotherapy, and bioinformatics, combined with clinical insights empowering solution. The solution involved the integration of various advanced technologies to provide a seamless, scalable platform for clinical trial matching.
Key technical components included:
AI Models for Data Inconsistency Detection: The AI models were trained to identify discrepancies across multiple data sources. By cross-referencing trial data against pre-established patterns, historical data, and clinical benchmarks, the system could pinpoint inconsistencies that might have otherwise gone unnoticed. Once identified, the system flagged these inconsistencies for immediate review and resolution.
Missing Data Identification and Rectification: Missing data is one of the most significant issues in clinical trials, often resulting from incomplete forms, errors in data entry, or patients dropping out. The AI models were designed to not only identify missing data points but also suggest possible values based on statistical patterns, predictive models, and available contextual information. This helped fill gaps in a way that maintained the integrity of the data, ensuring completeness for analysis.
Anomaly Detection: The AI system employed advanced machine learning algorithms to detect outliers or anomalies in trial data, such as unexpected spikes in measurements or unusual patient outcomes. By analyzing trends over time and comparing them to historical patterns, the system could quickly identify anomalies that might indicate issues like data entry errors or experimental biases.
Standardization to Regulatory Standards: After detecting and correcting errors, the data was standardized to the CDISC SDTM (Study Data Tabulation Model) standards, which are recognized by regulatory authorities like the FDA and EMA.
Technologies Used
MolecularMatch Algorithm: A proprietary algorithm that drives precise clinical trial matching by considering genomic and clinical factors.
AWS SageMaker: Used for model training, data processing, and real-time predictions, enabling the deployment of scalable machine learning models.
Docker: Containerization of models to ensure scalable and efficient deployment.
RESTful APIs: For real-time integration with external systems, providing seamless access to trial recommendations.
Cloud Infrastructure: Powered by AWS, ensuring scalability and real-time data processing capabilities.
Driving Precision, Speed, and Enrollment Efficiency in Clinical Trials
The Clinical Trial Match solution brought about substantial improvements in trial matching accuracy, speed, and patient access:
The predictive algorithm enhanced the accuracy of matching patients to relevant clinical trials. By processing detailed genomic, clinical, and demographic data, the platform generated more precise trial recommendations, leading to better treatment outcomes for patients.
The use of real-time machine learning models significantly reduced the time it took to match patients with clinical trials. What previously took 2-4 weeks was now completed in 4 to 8 hours, providing faster, actionable insights to facilitate trial enrollment.
The integration of genomic and clinical data ensured that patients had access to a broader range of clinical trials, including rare and specialized studies that were previously hard to identify. This expanded access allowed for bettertreatment options and a higher likelihood of success.
The solution led to a higher rate of patient enrollment in clinical trials. By streamlining the matching process, more patients were quickly identified for suitable trials, which accelerated research timelines and improved treatment options for patients
The Clinical Trial Match solution successfully transformed the process of matching patients to clinical trials by leveraging predictive analytics, machine learning, and scalable cloud infrastructure. This solution provides better access to life-saving clinical trials.
How Ideas2IT Built an AI-Powered Clinical Trial Match Platform for a Leading Pharmaceutical Company
How Ideas2IT Built an AI-Powered Clinical Trial Match Platform for a Leading Pharmaceutical Company
Solutions Deployed:
MolecularMatch Search Engine
Real-Time Predictions
Cloud-Based Infrastructure for Scalability
Vertical:
Pharma & Life Sciences
Overcoming Inefficiencies in Clinical Trial Patient Matching
Matching patients to the correct clinical trials has traditionally been inefficient and error-prone, often relying on manual processes and incomplete data. These challenges resulted in missed opportunities, slowing down the trial enrollment process and affecting treatment timelines.The client faced significant challenges in accurately matching patients with suitable clinical trials. Traditional methods could not process large, complex datasets, leading to delays in finding appropriate trials, missed enrollment opportunities, and suboptimal trial recruitment.
AI-Powered Solution for Enhanced Trial Matching Accuracy
The Clinical Trial Match solution was designed by Ideas2it leveraging MolecularMatch, a leader in clinical informatics company with expertise in precision oncology, immunotherapy, and bioinformatics, combined with clinical insights empowering solution. The solution involved the integration of various advanced technologies to provide a seamless, scalable platform for clinical trial matching.
Key technical components included:
AI Models for Data Inconsistency Detection: The AI models were trained to identify discrepancies across multiple data sources. By cross-referencing trial data against pre-established patterns, historical data, and clinical benchmarks, the system could pinpoint inconsistencies that might have otherwise gone unnoticed. Once identified, the system flagged these inconsistencies for immediate review and resolution.
Missing Data Identification and Rectification: Missing data is one of the most significant issues in clinical trials, often resulting from incomplete forms, errors in data entry, or patients dropping out. The AI models were designed to not only identify missing data points but also suggest possible values based on statistical patterns, predictive models, and available contextual information. This helped fill gaps in a way that maintained the integrity of the data, ensuring completeness for analysis.
Anomaly Detection: The AI system employed advanced machine learning algorithms to detect outliers or anomalies in trial data, such as unexpected spikes in measurements or unusual patient outcomes. By analyzing trends over time and comparing them to historical patterns, the system could quickly identify anomalies that might indicate issues like data entry errors or experimental biases.
Standardization to Regulatory Standards: After detecting and correcting errors, the data was standardized to the CDISC SDTM (Study Data Tabulation Model) standards, which are recognized by regulatory authorities like the FDA and EMA.
Technologies Used
MolecularMatch Algorithm: A proprietary algorithm that drives precise clinical trial matching by considering genomic and clinical factors.
AWS SageMaker: Used for model training, data processing, and real-time predictions, enabling the deployment of scalable machine learning models.
Docker: Containerization of models to ensure scalable and efficient deployment.
RESTful APIs: For real-time integration with external systems, providing seamless access to trial recommendations.
Cloud Infrastructure: Powered by AWS, ensuring scalability and real-time data processing capabilities.
Driving Precision, Speed, and Enrollment Efficiency in Clinical Trials
The Clinical Trial Match solution brought about substantial improvements in trial matching accuracy, speed, and patient access:
The predictive algorithm enhanced the accuracy of matching patients to relevant clinical trials. By processing detailed genomic, clinical, and demographic data, the platform generated more precise trial recommendations, leading to better treatment outcomes for patients.
The use of real-time machine learning models significantly reduced the time it took to match patients with clinical trials. What previously took 2-4 weeks was now completed in 4 to 8 hours, providing faster, actionable insights to facilitate trial enrollment.
The integration of genomic and clinical data ensured that patients had access to a broader range of clinical trials, including rare and specialized studies that were previously hard to identify. This expanded access allowed for bettertreatment options and a higher likelihood of success.
The solution led to a higher rate of patient enrollment in clinical trials. By streamlining the matching process, more patients were quickly identified for suitable trials, which accelerated research timelines and improved treatment options for patients
The Clinical Trial Match solution successfully transformed the process of matching patients to clinical trials by leveraging predictive analytics, machine learning, and scalable cloud infrastructure. This solution provides better access to life-saving clinical trials.
Enter your email to access the full case study
Connect with Us
We'd love to brainstorm your priority tech initiatives and contribute to the best outcomes.
From Manual Matching to Real-Time Precision: A Case Study in Clinical Trial Enrollment Acceleration
One-liner summary:
A global pharmaceutical company partnered with Ideas2IT to build an AI-powered trial matching platform that reduced patient-trial matching time from weeks to hours, increasing enrollment accuracy across oncology and rare disease studies.
Industry
Pharma & Life Sciences
Location
USA
Tech Stacks
Challenge
Manual, error-prone processes delayed patient-to-trial matching, leading to missed enrollments, slower timelines, and underutilized clinical programs.
The Problem with the Status Quo
A leading life sciences company faced a persistent bottleneck in clinical trial enrollment. Patient-trial matching was manual, error-prone, and slow. Clinical sites operated on disconnected data, inconsistent workflows, and static eligibility checks, resulting in missed enrollment windows and delayed trial timelines.
With expanding research portfolios in oncology and immunotherapy, the need was clear: improve precision and scale enrollment without adding operational burden.
Where the Gaps Were
The client’s existing systems could not handle high-dimensional, fast-changing datasets, especially genomic data from NGS panels and rare disease cohorts.
Challenges included:
2–4 week matching cycles based on static rule sets and manual data review
Low accuracy in identifying eligible patients for complex trial protocols
No live visibility into trial availability or evolving inclusion criteria
Inability to factor in real-time indicators like ECOG scores, comorbidities, or resistance biomarkers
This led to slower trial activation, fewer patient enrollments, and missed opportunities for care delivery and research impact
What We Delivered
Ideas2IT collaborated with MolecularMatch, a clinical informatics leader, to build a precision-driven trial match platform integrating molecular, clinical, and operational data into one intelligent workflow.
Core Capabilities and Architecture:
Matching Algorithm: Proprietary engine combining clinical, genomic, and histological data to deliver high-specificity trial ranking
Live Search Engine: Continuously refreshed trial database matched against real-time patient records
Advanced Filters: Match refinement based on tumor type, mutation profile, ECOG performance, and prior treatment history
Cloud-Native Infrastructure: Dockerized microservices on AWS supporting multi-site scalability and secure deployment
Workflow Integration: REST APIs deliver trial recommendations directly into care team systems and clinical platforms
This system enabled trial-matching intelligence to flow from genomic labs to care teams within hours.
Outcomes We Achieved
Metric
Outcome
Matching time
Reduced from 2–4 weeks to under 8 hours
Match accuracy
Increased by using integrated genomic and clinical data
Trial visibility
Broader access to rare and niche study protocols
Enrollment speed
Faster identification and recruitment across sites
The platform now powers real-time enrollment support across oncology and immunotherapy trials bringing more eligible patients into life-saving studies.
Industry
Pharma & Life Sciences
Location
USA
Tech Stacks
Challenge
Manual, error-prone processes delayed patient-to-trial matching, leading to missed enrollments, slower timelines, and underutilized clinical programs.
Key Takeaways
Combine clinical and genomic context. Matching precision increases only when both data layers are used together
Real-time infrastructure is essential. Static workflows are too slow for modern recruitment targets
APIs outperform dashboards. Embedded integration into care workflows is what drives daily adoption
